Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Introduction<p>Although the transcatheter arterial chemoembolization (TACE) combined with sintilimab and bevacizumab improves outcomes in unresectable HCC (uHCC), predictive tools are lacking. This study developed and validated a prognostic model for triple therapy efficacy.</p>Methods&l...

全面介紹

Saved in:
書目詳細資料
主要作者: Liying Ren (11143129) (author)
其他作者: Dongbo Chen (10430738) (author), Xue Zhang (166886) (author), Shaoping She (22678979) (author), Ran Fei (93650) (author), Xu Cong (159269) (author), Shaowei Mu (22678982) (author), Yuchen Zhou (1601536) (author), Jie Gao (10266) (author), Weijia Liao (492662) (author), Hongsong Chen (159274) (author)
出版: 2025
主題:
Genetic Immunology
hepatocellular carcinoma
immunotherapy
transcatheter arterial chemoembolization
prognostic model
FAAP score
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
成為第一個發表評論!
您必須先登錄

相似書籍